Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-4 of 4
Keywords: Sulfadoxine
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1987) 33 (1): 1–8.
Published Online: 09 September 2009
...D.E. Schwartz; E. Weidekamm; I. Mimica; P. Heizmann; R. Portmann Fansimef® is a new antimalarial combination containing pyrimethamine, sulfadoxine and mefloquine in the weight proportions 1+20+10. It has been designed to fight plasmodia resistant to the presently used antimalarial drugs...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1987) 33 (4): 229–233.
Published Online: 09 September 2009
...Michael D. Edstein The pharmacokinetics of sulfadoxine (SULF) and pyrimethamine (PYR) were studied in 7 healthy volunteers after a single oral dose of Fansidar®. A comparison was made between the pharmacokinetics of the components of Fansidar calculated from whole blood and plasma data. The mean...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1987) 33 (4): 259–265.
Published Online: 09 September 2009
...E. Weidekamm; D.E. Schwartz; U.C. Dubach; B. Weber Fansimef® is a new oral schizonticide which contains pyrimethamine (P), sulfadoxine (S) and mefloquine (M) in a weight ratio of 1:20:10. This antimalarial combination is highly active against multi-resistant Plasmodium falciparum and in vitro...
Journal Articles
Journal:
Chemotherapy
Chemotherapy (1990) 36 (3): 177–184.
Published Online: 09 September 2009
...N.S. Wang; X.B. Guo; Q.D. Liu; L.C. Fu; G.Q. Li; K. Arnold The oral single-dose pharmacokinetics and bioavailability of mefloquine (M) in combination with pyrimethamine (P) and sulfadoxine (S) from a single non-lacquered tablet (NL; M 250 mg, P 25 mg, S 500 mg) and two lacquered tablets (L; M 125...
